4933403F05Rik Activators are a curated collection of chemical compounds that enhance the functional activity of the protein 4933403F05Rik through various specific intracellular pathways. Forskolin and Ionomycin both increase intracellular levels of second messengers, cAMP, and calcium, respectively, which activate protein kinases like PKA and calcium-dependent kinases that may phosphorylate proteins interacting with 4933403F05Rik, thus enhancing its activity. The activation of PKC by PMA and the inhibition of competitive signaling by EGCG could also indirectly heighten the functional role of 4933403F05Rik in cellular processes. Similarly, the blockade of PI3K signaling by LY294002 shifts the balance towards pathways that could activate 4933403F05Rik, while the inhibition of key MAPK components by SB203580 and U0126 may redirect signaling through alternative routes that promote 4933403F05Rik activity.
4933403F05Rik Activators encompass a range of chemical compounds that enhance the specific biological activity of the protein 4933403F05Rik through distinctive signaling pathways. Compounds such as Forskolin and Ionomycin engage in the elevation of intracellular second messengers, with Forskolin raising cAMP levels and Ionomycin increasing calcium concentrations, both of which activate corresponding protein kinases. These kinases, such as PKA and calcium-dependent kinases, may directly phosphorylate and activate regulatory proteins that interact with 4933403F05Rik, leading to its functional enhancement. Similarly, PMA serves as an activator of protein kinase C, which can phosphorylate a broad range of proteins, potentially including those that regulate the activity of 4933403F05Rik. The activity of 4933403F05Rik is further influenced by EGCG, which inhibits competitive signaling pathways, thereby potentially freeing up additional kinases to activate 4933403F05Rik-related pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels. This can trigger calcium-dependent protein kinases that potentially phosphorylate and enhance the activity of 4933403F05Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which can phosphorylate a broad range of target proteins. PKC-mediated phosphorylation pathways may include substrates that modulate the activity of 4933403F05Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known for its inhibitory effect on various protein kinases. The inhibition of competitive kinase pathways by EGCG could enhance the signaling pathways in which 4933403F05Rik operates. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which can shift the balance of intracellular signaling towards pathways that activate 4933403F05Rik by reducing competitive PI3K/Akt signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, which may lead to the activation of alternative signaling pathways favoring the activity of 4933403F05Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is involved in signaling pathways that regulate cellular processes such as proliferation and survival, which could include the activation of 4933403F05Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, potentially activating calcium-dependent pathways that interact with 4933403F05Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, similar to Ionomycin, and may activate calcium-dependent kinases that enhance the activity of 4933403F05Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that might lead to the selective activation of pathways involving 4933403F05Rik by reducing the inhibition of kinases specific to its activation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could activate signaling pathways where 4933403F05Rik is involved by decreasing competitive tyrosine kinase signaling. | ||||||